Hepatitis B seroprevalence in HIV-infected patients consulting in a public day care unit in Bobo Dioulasso, Burkina Faso

2013

Article référencé dans le Web of Science WOS:000322099900005

Bado G., Penot P., N'Diaye M. D., Amiel C., Hema A., Kamboule E. B., Guiard-Schmid J. B., Kabore N. F., Slama L., Bambara A., Laurent Christian, Sangare L., Sawadogo A. B.

Medecine et Maladies Infectieuses, 2013, 43 (5), p. 202-207 ISSN 0399-077X

Objective. - The authors had for aim to assess the prevalence of hepatitis B co-infection in a cohort of HIV-infected patients, routinely followed-up at the Day Care Unit of the Bobo Dioulasso Sanou Souro University Hospital, Burkina Faso. Patients and methods. - The Elisa technique was used to dose HBs antigen (AgHBs), antibodies anti-HBs and anti-HBc in all the patients followed by the biological laboratory, from October to December 2008. Results. - The AgHBs prevalence was 12.7% [CI at 95%; 10.7-15.0%] and men were slightly more likely to be positive for AgHBs than women (16.5% [12.0-21.9%] versus 11.6% [9.4-14.1%]; P = 0.047); 83.3% of the patients [80.8-85.6%] were positive for hepatitis B core antibody, and 32.6% [29.7-35.6%] for hepatitis B surface antibody; 29.9% of the patients [27.1-32.8%] had a complete profile of former hepatitis B infection, 41.3% [38.2-44.4%] expressed core antibodies only; 13.8% [11.7-16.0%] had a negative serological test, and 2.3% [1.5-3.4%] presented a vaccinal immunity. Conclusion. - These results stress the usefulness of screening for hepatitis B in all HIV-infected patients, along with the initial biological tests. This would help adapt HIV treatment to co-infected patients and to build an expanded program of vaccination for non-immune patients.

Entomologie médicale / Parasitologie / Virologie [052]

BURKINA FASO

Fonds IRD [F B010060509]

fdi:010060509